The meta-analysis did not show any difference between the sample systems (subgroup difference P = 0.70), and no significant change in VEGF levels for infants with ROP was identified in either of the systems (Supplement Appendix 3, Fig S33, available at www.ophthalmologyscience.org). The gene discussed is VEGFA; the disease is retinopathy of prematurity.